PLoS ONEGeneticsPeer-reviewed journal article
Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
Abstract
Understanding how human ACE2 genetic variants differ in their recognition by SARS-CoV-2 can have a major impact in leveraging ACE2 as an axis for treating and preventing COVID-19. In this work, we experimentally interrogate thousands of ACE2 mutants to identify over one hundred human single-nucleotide variants (SNVs) that are likely to have altered recognition by the virus, and make the complementary discovery that ACE2 residues distant from the spike interface can have a strong influence upon the ACE2-spike interaction. These findings illuminate new links between ACE2 sequence and spike recognition, and will find wide-ranging utility in SARS-CoV-2 fundamental research, epidemiological analyses, and clinical trial design.
- Citations
- 19
- FWCI
- 1.43
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural Genetics of circulating variants affecting the SARS CoV-2 Spike / human ACE2 complex
Francesco Ortuso, Daniele Mercatelli, … Federico Manuel Giorgi·Journal of Biomolecular Structure and DynamicsPeer-reviewed·Feb 13, 2021
- Missense variants in human ACE2 modify binding to SARS-CoV-2 Spike
Stuart A. MacGowan, Michael I. Barton, … Geoffrey J. Barton·PLoS Computational BiologyPeer-reviewed·Mar 2, 2022
- Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility
Kushal Suryamohan, Devan C. Diwanji, … Somasekar Seshagiri·Communications BiologyPeer-reviewed·Apr 12, 2021
- Susceptibilities of human ACE2 genetic variants in coronavirus infection
- Decomposition of the SARS-CoV-2-ACE2 interface reveals a common trend among emerging viral variants
Eileen Socher, Marcus Conrad, … Philipp Arnold·Journal of Cellular BiochemistryPeer-reviewed·Sep 13, 2021
- Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19
Stuart A. MacGowan, Geoffrey J. Barton·bioRxiv·May 3, 2020